# NeoRad Breast Cancer Study

> **NCT04261244** · PHASE3 · RECRUITING · sponsor: **Bielefeld University** · enrollment: 1826 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **RADIATION:** preoperative radiotherapy
- **RADIATION:** postoperative radiotherapy

## Key facts

- **NCT ID:** NCT04261244
- **Lead sponsor:** Bielefeld University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2028-03-31
- **Final completion:** 2034-03-31
- **Target enrollment:** 1826 (ESTIMATED)
- **Last updated:** 2025-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261244, "NeoRad Breast Cancer Study". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT04261244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*